Horvatits T, Pischke S, Proske V M, Fischer L, Scheidat S, Thaiss F, Fuhrmann V, Lohse A W, Nashan B, Sterneck M
Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
United European Gastroenterol J. 2018 Feb;6(1):104-111. doi: 10.1177/2050640617707089. Epub 2017 Apr 21.
Since introduction of the MELD score in the liver allograft allocation system, renal insufficiency has emerged as an increasing problem. Here we evaluated the course of kidney function in patients with advanced renal insufficiency prior to liver transplantation (LT).
A total of 254 patients undergoing LT at the University Medical Centre Hamburg-Eppendorf (2011-2015) were screened for renal impairment (GFR < 30 ml/min) prior to LT in this observational study.
Eighty (32%) patients (median 60 years; M/F: 48/32) had significant renal impairment prior to LT. Median follow-up post-LT was 619 days. Patient survival at 90 days, one year and two years was 76%, 66% and 64%, respectively. Need for dialysis postoperatively but not preoperatively was associated with increased mortality ( < 0.05). Renal function improved in 75% of survivors, but 78% of patients had chronic kidney disease ≥ stage 3 at end of follow-up. Of eight (16%) survivors remaining on long-term dialysis, so far only four patients have received a kidney transplant.
Postoperative dialysis affected long-term mortality. In 75% of survivors renal function improved, but still the majority of patients had an impaired renal function (CKD stage 3-5) at end of follow-up. Future studies should elucidate the impact of kidney dysfunction and dialysis on recipients' long-term survival.
自从在肝脏移植分配系统中引入终末期肝病模型(MELD)评分以来,肾功能不全已成为一个日益严重的问题。在此,我们评估了肝移植(LT)术前晚期肾功能不全患者的肾功能进程。
在这项观察性研究中,对汉堡-埃彭多夫大学医学中心2011年至2015年期间接受肝移植的254例患者进行了肝移植术前肾功能损害(肾小球滤过率<30ml/分钟)筛查。
80例(32%)患者(中位年龄60岁;男/女:48/32)在肝移植术前有明显的肾功能损害。肝移植术后中位随访时间为619天。术后90天、1年和2年的患者生存率分别为76%、66%和64%。术后而非术前需要透析与死亡率增加相关(P<0.05)。75%的幸存者肾功能有所改善,但78%的患者在随访结束时患有慢性肾脏病≥3期。在8例(16%)仍需长期透析的幸存者中,到目前为止只有4例患者接受了肾移植。
术后透析影响长期死亡率。75%的幸存者肾功能有所改善,但在随访结束时,大多数患者的肾功能仍受损(慢性肾脏病3-5期)。未来的研究应阐明肾功能不全和透析对受者长期生存的影响。